Combined Synopsis/Solicitation for P/ACE MDQ Plus (Sole Source)

Closed Solicitation Posted

Solicitation number
75D301-24-Q-78047
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Atlanta, Georgia 30341, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Centers for Disease Control and Prevention (CDC) is issuing a sole source solicitation for the procurement of one P/ACE MDQ Plus Capillary Electrophoresis System. The CDC has determined that AB SCIEX LLC is the sole manufacturer and distributor of this specialized equipment. Responses must be received by 12:00 P.M. EDT on August 9, 2024, and should include the total price for the system with 30-day delivery to the CDC Distribution Center in Chamblee, Georgia. The acquisition falls under NAICS code 334516 for Analytical Laboratory Instrument Manufacturing, with a small business size standard of 1000 employees. Offerors must be registered in the System for Award Management to be eligible for award.

This is an unrestricted procurement, with no set-aside designations. The total estimated value of the contract is $65,038.35. The CDC currently owns an older MDQ system from the same manufacturer, and is seeking to acquire the newer P/ACE MDQ Plus model to enhance the capabilities of its Division of Core Laboratory Services and Response.

Notice text

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Requirements (FAR) Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation will not be issued.

The solicitation number for this requirement is 75D301-24-Q-78047 and is hereby issued as a Request for Quote (RFQ) using FAR Subpart 13.1 Simplified Acquisition Procedures.

Market research indicates that AB SCIEX LLC, a large business, is the the manufacturer and sole distributor of the P/ACE MDQ Plus Capillary Electrophoresis System.  As such, CDC shall negotiate a sole source award to AB SCIEX LLC.

The Centers for Disease Control and Prevention intends to award a firm-fixed-price contract for the following requirement, please either fill in the dollar amounts or provide a separate excel spreadsheet containing the same information including a list of line item number(s) and items, quantities, units of measure, and options, if applicable: 

ITEM  SUPPLIES / SERVICES                                   QTY / UNIT     UNIT PRICE        EXTENDED PRICE

0001   P/ACE MDQ Plus Capillary Electrophoresis    1 Each

Your quote shall include the following:

  • Total Price for CLIN 0001

Delivery Date: 30 days after contract award

Delivery Address: CDC Distribution Center, 3719 N. Peachtree Rd., Chamblee, GA 30341

Acceptance and FOB point

The quote format is at the discretion of the offeror.

It is the offeror's responsibility to be familiar with the applicable clauses and provisions which can be found on the attachment labeled, 75D301-24-Q-78047 _ Clauses and Provisions. Also, all clauses and provisions may be accessed via the Internet at www.acquisition.gov.

This solicitation document and incorporated provisions and clauses are those in effect through the Federal Acquisition Circular (FAC) 2024-05 (May 22, 2024).

This acquisition is under North American Industry Classification System (NAICS) code 334516 with small business size standard of 1000 employees. A Firm-Fixed Price purchase order will be issued in writing to the successful offeror. To be eligible to receive an award resulting from this solicitation, contractor must be registered in the System for Award Management. To register apply via the Internet at www.sam.gov. For questions on registration contact Federal Service Desk at 866-606-8220.

Include FAR 52.212-3, Offeror Representations and Certifications with Offer or indicate if it is available online at www.sam.gov.

No telephonic quotes will be processed. All responses must be received no later than 12:00 P.M., EDT on 09 August 2024. Please send any questions and quotes to James Brown III at xvn8@cdc.gov.

Attachments:

  1. 75D301-24-Q-78047 _ Combined Synopsis/Solicitation
  2. 75D301-24-Q-78047 _ Clauses and Provisions
  3. 75D301-24-Q-78047 _SSJ_Redacted

Files

Similar open opportunities

Opportunity Agency Set-aside Responses due
Notice of Intent to Sole Source a Thermo Orbitrap Fusion Lumos and Thermo RSLCnano UPLC Maintenance Agreement Georgia 30329, United States · NAICS 811210 CDC Office of Acquisition Services No set-aside
Notice of Intent to Sole Source – AB Sciex LLC Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside
Single Purchase of an Agilent 8890 GC System Custom with dual ECD detectors NAICS 221310 EPA Region 4 No set-aside
Safety, Prevention, Epidemiology, and Education Development for Health Care and Antimicrobial Resistance - SPEED 2027-2032 Atlanta, Georgia 30341, United States · NAICS 541690 CDC Office of Acquisition Services Partial Small Business
Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity